Overview
Toshinori Hyodo practices practicing medicine in Nagakute, Japan.
Their clinical expertise encompasses Mesothelioma, Rhabdomyosarcoma, Multiple Myeloma, and Oral Cancer.
They are actively involved in clinical research, co-authoring 45 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Toshinori Hyodo
Is Toshinori Hyodo a top-rated expert for Mesothelioma?
MediFind is an objective health platform that identifies experts based on real-world data. Toshinori Hyodo is classified as an Experienced expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Toshinori Hyodo participate in research or clinical trials?
Yes. Toshinori Hyodo has published 45 articles and abstracts on conditions like Mesothelioma. You can view a list of Toshinori Hyodo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- LeukemiaHyodo isExperienced. Learn about Leukemia.
- MesotheliomaHyodo isExperienced. Learn about Mesothelioma.
- Multiple MyelomaHyodo isExperienced. Learn about Multiple Myeloma.
- Oral CancerHyodo isExperienced. Learn about Oral Cancer.
- RhabdomyosarcomaHyodo isExperienced. Learn about Rhabdomyosarcoma.